Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Ann Thorac Surg. 2017 Jul 29;104(4):1221–1230. doi: 10.1016/j.athoracsur.2017.05.011

Figure 1.

Figure 1

Survival for patients with atypical lung carcinoids by nodal status, NCDB 2006–2011

Estimate Overall Node Negative Node Positive P value
12-month survival 97.3% (95.9–98.7%) 96.5% (94.5–98.5%) 98.6% (97–100%)
60-month survival 73.5% (69.2–78.1%) 82.2% (77.5–87.2%) 59.8% (52.2–68.6%)
Median survival 100.2 months NA months 70.7 months <0.001
NCDB National Cancer Data Base, N0 pathologically node negative, N+ pathologically node positive